# Racial Differences in Care Quality Among Men With Newly Diagnosed Prostate Cancer

**Authors:** Dawson C. Hill, Samuel R. Kaufman, Christopher Dall, Paula Guro, Sarah Leick, Preeti Chachlani, Xiu Liu, Addison Shay, Mary Oerline, Rishi R. Sekar, Lindsey A. Herrel, Brent K. Hollenbeck, Vahakn B. Shahinian, Arnav Srivastava

PMC · DOI: 10.1001/jamanetworkopen.2025.23038 · JAMA Network Open · 2025-07-24

## TL;DR

The study explores differences in the quality of prostate cancer care received by men of different races in the Medicare system.

## Contribution

The novelty lies in analyzing racial disparities in confirmatory testing and treatment among newly diagnosed prostate cancer patients.

## Key findings

- Racial disparities in care quality were identified among Medicare beneficiaries with newly diagnosed prostate cancer.
- The study highlights variations in confirmatory testing and potential overtreatment based on race.

## Abstract

This cross-sectional study examines racial disparities in care quality, including confirmatory testing and potential overtreatment, among Medicare beneficiaries with newly diagnosed prostate cancer.

## Linked entities

- **Diseases:** prostate cancer (MONDO:0005159)

## Full-text entities

- **Diseases:** Prostate Cancer (MESH:D011471)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12290725/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12290725/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12290725/full.md

---
Source: https://tomesphere.com/paper/PMC12290725